Ticker
ADMA

Price
2.68
Stock movement down
-0.03 (-1.11%)
Company name
ADMA Biologics Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Markedsverdi
526.22M
Ent verdi
637.82M
Pris/omsetning
9.48
Pris/bok
4.15
Utbytte avkastning
-
Utbytte vekst
-
Vekst år
-
FCF-utbetaling
-
Etterfølgende P/E
-
Fremtidig P/E
-
PEG
-
EPS-vekst
-
1 års avkastning
92.81%
3 års avkastning
-14.91%
5 års avkastning
-2.17%
10 års avkastning
-
Sist oppdatert: 2022-08-25

UTBYTTE

ADMA betaler ikke utbytte

VERDSETTELSE

Verdsettelsesforhold

Loading...
Verdsettelsesforhold-data
Etterfølgende P/E-
Pris til OCF-
Pris til FCF-
Pris til EBITDA-
EV i forhold til EBITDA-

Verdsettelse (Salg/Bokført verdi)

Loading...
Verdsettelse (Salg/Bokført verdi) data
Pris til omsetning9.48
Pris til bok4.15
EV i forhold til salg11.50

ØKONOMI

Per aksje

Loading...
Per aksje-data
Gjeldende aksje antall196.35M
EPS (TTM)-0.43
FCF per aksje (TTM)-0.66

Resultatregnskap

Loading...
Resultatregnskap-data
Inntekter (TTM)55.49M
Bruttofortjeneste (TTM)-31.95M
Driftsinntekter (TTM)-58.02M
Netto inntekt (TTM)-78.28M
EPS (TTM)-0.43
EPS (1 år fremover)-0.14

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)-57.59%
Driftsmargin (TTM)-104.58%
Fortjenestemargin (TTM)-141.07%

Balanse

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Balanse-data
Kontanter69.50M
Netto fordringer25.63M
Samlede omløpsmidler239.80M
Goodwill3.53M
Immaterielle eiendeler1.55M
Eiendom, anlegg og utstyr53.22M
Sum eiendeler308.03M
Leverandørgjeld14.12M
Kortsiktig/nåværende langsiktig gjeld146.36M
Sum kortsiktig gjeld31.57M
Sum gjeld181.10M
Aksjonærenes egenkapital126.93M
Netto varige driftsmidler126.93M

Kontantstrøm

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Kontantstrøm-data
Kontantstrøm fra drift (TTM)-105.15M
Kapitalutgifter (TTM)13.78M
Fri kontantstrøm (TTM)-118.94M
Utbetalt utbytte (TTM)0.00

Finansielle inntekter

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Finansielle inntekter-data
Egenkapitalavkastning-61.67%
Avkastning på eiendeler-25.41%
Avkastning på investert kapital-19.39%
Kontantavkastning på investert kapital-29.46%

AKSJEINFORMASJON

Aksjediagram

Loading...
Aksjekurs-data
Åpning2.70
Daglig høy2.74
Daglig lav2.65
Daglig volum1.92M
Tidenes høyeste12.49
1 år analytikerestimat5.13
Beta1.02
EPS (TTM)-0.43
Utbytte per aksje-
Ex-div dato-
Neste dato for resultatpresentasjon8 Nov 2022

Nedsidepotensial

Loading...
Nedsidepotensial-data
ADMAS&P500
Nåværende prisfall fra toppnotering-78.54%-12.18%
Høyeste prisfall-91.27%-56.47%
Dato for høyeste fall11 Oct 20219 Mar 2009
Gj.snittlig fall fra topp-57.42%-11.38%
Gj.snittlig tid til ny topp91 days12 days
Maks tid til ny topp1948 days1805 days
SELSKAPSOPPLYSNINGER
ADMA (ADMA Biologics Inc) company logo
Markedsverdi
526.22M
Markedsverdi kategori
Small-cap
Beskrivelse
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Ansatte
527
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Adam S. Grossman
Land
USA
By
Ramsey
Aksjetype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
FORSTÅ VIRKSOMHETEN
Loading...
NYHETER OM SELSKAPET
Alle nyheterPressemeldinger
A new White House program will likely boost the entire biotech industry. And it makes these seven names some outstanding biotech stocks to buy for the fourth quarter. The new National Biotechnology an...
15. september 2022
Penny stocks are those which typically trade at $5 per share or less. Most penny stocks represent small companies that likely trade via over-the-counter (OTC) transactions, although some do trade on ...
31. august 2022
ADMA Biologics (NASDAQ: ADMA), typically one of the more under-the-radar coronavirus stocks, was very much on the radar of many investors on Thursday. ADMA attracted a degree of renown in 2020 after ...
11. august 2022
Adma Biologics (ADMA) delivered earnings and revenue surprises of 22.22% and 8.77%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
10. august 2022
2Q2022 Total Revenues Were $33.9 Million, a 90% Y-o-Y Increase Grew 2Q2022 Gross Profit to $7.8 Million, Up 112% Over 1Q2022 Narrowed 2Q2022 Net Losses to $13.8 Million, a 45% Improvement Over 1Q2022 ...
10. august 2022
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
10. august 2022
Vascular Biogenics (VBLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
8. august 2022
Adma Biologics (ADMA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3. august 2022
Conference Call Scheduled for August 10, 2022, at 4:30 p.m. ETRAMSEY, N.J. and BOCA RATON, Fla., Aug. 03, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end...
3. august 2022
While not a mind-blowing move, it is good to see that the ADMA Biologics, Inc. ( NASDAQ:ADMA ) share price has gained...
26. juni 2022
Neste side